SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-003851
Filing Date
2015-08-18
Accepted
2015-08-18 06:13:53
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 578368
2 ex31-1.htm EX-31.1 18100
3 ex31-2.htm EX-31.2 17940
4 ex32-1.htm EX-32.1 7195
5 ex32-2.htm EX-32.2 7439
  Complete submission text file 0001493152-15-003851.txt   4124546

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aker-20150630.xml EX-101.INS 690813
7 XBRL SCHEMA FILE aker-20150630.xsd EX-101.SCH 57417
8 XBRL CALCULATION FILE aker-20150630_cal.xml EX-101.CAL 64435
9 XBRL DEFINITION FILE aker-20150630_def.xml EX-101.DEF 169158
10 XBRL LABEL FILE aker-20150630_lab.xml EX-101.LAB 412345
11 XBRL PRESENTATION FILE aker-20150630_pre.xml EX-101.PRE 283565
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences Inc (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 151060122
SIC: 2835 In Vitro & In Vivo Diagnostic Substances